Metabolic effects of structured triglycerides in humans.
This review considers the development of structured triglycerides as an IV nutrient source. The replacement of a portion of long-chain fatty acids in the conventional fat emulsion triglycerides confers favorable qualities on these lipids and renders them attractive as an energy source, particularly in critically ill patients. This report considers the features of structured triglycerides that may make them competitive or even more efficient as an energy source compared with conventional fat emulsions.
Hyltander
A
A
Sandström
R
R
Lundholm
K
K
D002986:Clinical Trials as Topic; D016638:Critical Illness / Q000628:therapy*; D005217:Fat Emulsions, Intravenous / Q000737:chemistry / Q000378:metabolism* / Q000627:therapeutic use; D005231:Fatty Acids, Unsaturated / Q000737:chemistry / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D014280:Triglycerides / Q000737:chemistry / Q000378:metabolism* / Q000627:therapeutic use
D005217:Fat Emulsions, Intravenous; D005231:Fatty Acids, Unsaturated; D014280:Triglycerides